AdvisorShares Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-273,401
| Closed | -$1.45M | – | 236 |
|
|
2021
Q2 | $1.45M | Sell |
273,401
-1,264,138
| -82% | -$6.69M | 0.2% | 65 |
|
|
2021
Q1 | $7.15M | Buy |
1,537,539
+927,494
| +152% | +$4.31M | 0.89% | 18 |
|
|
2020
Q4 | $2.01M | Buy |
610,045
+257,036
| +73% | +$849K | 0.47% | 22 |
|
|
2020
Q3 | $1.17K | Sell |
353,009
-27,676
| -7% | -$92 | 0.06% | 58 |
|
|
2020
Q2 | $1.28M | Buy |
380,685
+27,717
| +8% | +$93.4K | 0.55% | 24 |
|
|
2020
Q1 | $1.35M | Buy |
352,968
+83,253
| +31% | +$319K | 1.17% | 13 |
|
|
2019
Q4 | $1.63M | Buy |
+269,715
| New | +$1.63M | 1.01% | 12 |
|